CG Oncology, Inc. Common stock
Biotechnology
Healthcare
CGON
67.14 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
15.05
52 week high
39.94
high
18.40
52 week low
15.59
low
14.80
growth
-45.43 %
previous Close
15.59
P/E ratio
market cap
2.18 B
div yield
0
usd
Sep 2024
qoq
revenue
43.00 K
-61.26 %
net incoming
-20.41 M
-7.95 %
eps
0.00 %
-7.14 %
eps surprise
11.92 %
net profit margin
-47453.49 %
-30424.00 %
operating incoming
-28.30 M
-9.45 %
net change in cash
18.25 M
134.89 %
cash on hand
43.41 M
72.55 %
cost of revenue
0.00 %
top top